Skip to main content
SAGE Open Medical Case Reports logoLink to SAGE Open Medical Case Reports
. 2014 Mar 10;2:2050313X14527589. doi: 10.1177/2050313X14527589

Rheumatic heart disease in Tennessee: An overlooked diagnosis

Shahana A Choudhury 1,, Vernat Exil 2
PMCID: PMC4857350  PMID: 27489643

Abstract

Rheumatic heart disease, already a major burden in low- and middle-income countries, is becoming an emerging problem in high-income countries. Although acute rheumatic fever and rheumatic heart disease have almost been eradicated in areas with established economies, the emergence of this problem may be attributable to the migration from low-income to high-income settings. Between 2010 and 2012, we diagnosed a cluster of rheumatic heart disease cases in children from the Middle Tennessee area. The goal of this report is to increase awareness among clinicians as the incidence and prevalence of acute rheumatic fever remain relatively significant in large US metropolitan areas. Although acute rheumatic fever is seasonal, a high suspicion index may lead to the early diagnosis and prevention of its cardiac complications. Furthermore, screening procedures may be recommended for populations at risk for rheumatic heart disease in endemic areas, and active surveillance with echocardiography-based screening might become very important.

Keywords: Rheumatic heart disease, high-income communities, overlooked diagnosis

Introduction

Acute rheumatic fever (ARF) is a multi-system disease.1 Rheumatic heart disease (RHD) occurs in up to 80% of the patients with ARF. The mechanism of how ARF leads to RHD in select patient groups may include specific group A streptococcus (GAS) strains (serotypes 1, 3, 5, 6, 7, 18, 19, and 24), inherited host susceptibility, and pathologic autoimmunity. ARF is more common in younger patients (90%) than in older adolescents and adults.24

Although more than 80% of the ARF cases occur in low- and middle-income communities (LMICs), there has been resurgence in high-income communities (HIC). The purpose of this article is to review a cluster of RHD cases found in children who were seen in various Middle Tennessee clinics between 2010 and 2012. The goal of this report is to increase awareness among clinicians, as the incidence and prevalence of ARF remains relatively significant in large US metropolitan areas.

Patient reports

Case 1

A 7-year-old Caucasian female, a known asthmatic, was evaluated with a 1-week history of an increasing cough and exhibited no improvement with beta-agonist bronchodilators. She had a new grade III/VI systolic regurgitant murmur with a mid-systolic click noted at the apex, radiating to the left sternal border and the base of the heart, as well as diffuse expiratory wheezing and crepitation. The rest of her physical examination was unremarkable except for a body mass index at the fifth percentile and an elevated blood pressure of 115/74 mmHg. Her medical history included positive streptococcus pharyngitis tests at ages 5 and 6 years, which were adequately treated with antibiotics. Her echocardiogram report showed an enlarged left ventricle with decreased systolic function. There was also mild to moderate mitral valve regurgitation. She was treated with intramuscular benzathine penicillin G. She was also treated with a blood pressure–lowering agent, enalapril, to address her mitral valve regurgitation. Secondary prophylaxis with intramuscular benzathine penicillin G was initiated on an every 4-week regimen. Prophylaxis for sub-acute bacterial endocarditis (SBE) for surgical and dental procedures was recommended.5

Case 2

A 10-year-old Hispanic male in his usual good state of health was seen in a follow-up visit for a presumed viral illness associated with intermittent fevers, body aches, joint stiffness, dizziness, and paleness. His medical history was marked by one documented episode of an appropriately treated streptococcal pharyngitis 3 years prior to the current presentation. He had a grade II/VI systolic murmur at the base and apex of the heart and I/VI diastolic murmurs at the left and right upper sternal borders. Treatment and prophylaxis were appropriately instituted.5

Case 3

A 4¾-year-old Caucasian female presented with a 1 year history of recurrent fevers, sore throat, joint pain, and joint swelling, suggesting both arthralgia and arthritis. Her medical history was significant for recurrent episodes of streptococcal pharyngitis, which were adequately treated with amoxicillin or benzathine penicillin injections. On examination, she had a typical rash of multiple flat, painful, bluish-purple, and red bumps over both anterior knees consistent with erythema nodosum. On auscultation of her heart, she had a grade II/VI systolic murmur at the left sternal border. A presumptive diagnosis of ARF was made based on two major criteria (erythema nodosum and arthritis) and one minor criterion (fever).5 The patient’s family, however, refused secondary antibiotics prophylaxis treatments but did agree to continue close follow-ups with pediatric cardiology on a 6- to 12-month basis.

Case 4

On a routine well-child exam, an 8½-year-old African-American female with mild developmental delay was noted to have an irregular heart rhythm, a new II–III/VI systolic regurgitant heart murmur, an active precordium, and an erythematous throat. Her echocardiogram showed mitral valve prolapse and mitral valve regurgitation. The degree of mitral valve prolapse seen on her echocardiogram (Table 1), however, did not clinically justify the degree of mitral valve regurgitation. She was appropriately treated, and a secondary prophylaxis was instituted with intramuscular benzathine penicillin injections. The pediatric cardiology recommendation included an angiotensin-converting enzyme inhibitor (enalapril) for her moderate mitral valve regurgitation.

Table 1.

Laboratory, EKG, and echocardiographic findings in ARF/RHD cases.

Cases ASO (IU/mL, 0–200) Anti-DNaseB (IU/mL,<170 or EU, <20) ESR (mm) first hour CRP (0–0.79°mg/dL) GAS rapid antigen or culture EKG Echocardiogram
1 586 433 EU 1 0.4 Both negative Normal Moderate degree of mitral valve regurgitation, and enlargements of both the left ventricle and the left atrium
2 2238 37 EU 62 6.54 Both negative First-degree heart block Mild aortic and mitral valve regurgitations
3 393.7 1920 6 0.06 Both negative Border-line increase in QT interval Normal
4 654 1020 10 0.4 Positive culture Multiple PACs Moderate mitral regurgitation associated with thickened mitral valve leaflets and prolapsing of the anterior leaflet
5 981 697 Not done 44.8 Both negative Normal A trace of aortic valve insufficiency with moderate mitral valve insufficiency

EKG: electrocardiogram; RHD: rheumatic heart disease; ARF: acute rheumatic fever; EU: enzyme unit; GAS: group A streptococcus; ESR: erythrocyte sedimentation rate; PAC: premature atrial contraction; ASO: antistreptolysin O; CRP: C-reactive protein.

Case 5

A 9-year-old Hispanic female presented with a new grade II/VI systolic murmur in the setting of a routine physical examination. Her medical history was remarkable for one episode of pharyngitis and arthralgia for which she received amoxicillin 3 months prior to her clinic visit. She was treated with an intramuscular injection of benzathine penicillin, and a secondary prophylaxis of the same was continued.

Discussion

Although ARF and RHD have been almost eradicated in areas with established economies, the emergence of ARF may be attributable partly to migration.6 The prevalent hypotheses may include a high influx of individuals harboring “rheumatogenic” strains of the bacteria. These concerns also involve frequent global travelers, including active military personnel. Cases 1, 2, and 3 were seen in a suburban pediatric clinic with a high influx of the dependents from active duty military personnel housed at a nearby military base. Case 4 was a Hispanic girl seen in a clinic located in an urban area of Middle Tennessee. Although our report concentrated on only five cases from a small region of Tennessee, the burden of ARF may not be negligible in the United States. We hypothesize rheumatic fever cases in Middle Tennessee areas may be on the rise, warranting further epidemiological studies.

In this report, the diagnostic criteria for ARF and RHD are based primarily on clinical presentations (Jones criteria) and the echocardiogram results. Although case 1 did not strictly meet Jones minor criteria, a diagnosis of RHD was made based on echocardiogram results and evidence of past GAS infection. Therefore, it is important to note that a diagnosis of RHD can be made, or the suspicion of RHD can be raised based on the echocardiogram results, despite absence of the clinical Jones Criteria. With the exception of case 4, none of the cases had evidence of a positive Streptococcus pyogenes pharyngitis at the time of presentation. Laboratory test results for antistreptolysin O (ASO) titers and the anti-DNaseB were often delayed. Thus, heightened suspicion for early diagnosis is critical, as the condition can lead to cardiac complications that can be crippling to pediatric patients.

The prevalence of RHD in US populations is reported at less than 0.05 per 100,000, with rare outbreaks reported in Tennessee in the 1960s.7 The reported cases in this article may suggest that the actual incidence and prevalence of rheumatic fever may be underestimated in the United States, warranting further research. Based on our clinical cases, it may be recommended that high-risk population, including returning military personnel from deployment (or on ongoing assignments) should promptly seek medical attention in case of symptoms suggestive of streptococcus pharyngitis. Cost-benefit for asymptomatic individuals is prohibitive. Identification of GAS colonization or infection with “rheumatogenic” strains of the bacteria (In asymptomatic family members of index cases), and echocacardiographic screening might prove beneficial in patients with newly detected heart murmurs.8 These tests are undoubtedly simple and cost-effective. Additional studies might be needed to assess the epidemiology of ARF in at risk middle-income communities and HICs, which may help in the development and implementation of a continuous quality improvement strategy.9 This will further aid in the implementation of comprehensive strategies for the prevention and/or early detection of GAS infection in other vulnerable populations as well at risk for rheumatic fevers and rheumatic heart disease.

Footnotes

Declaration of conflicting interests: The authors declare that there is no conflict of interest.

Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

References

  • 1. Sanyal SK, Berry AM, Duggal S, et al. Sequelae of the initial attack of acute rheumatic fever in children from north India. A prospective 5-year follow-up study. Circulation 1982; 65: 375–379. PMID: 7053897. [DOI] [PubMed] [Google Scholar]
  • 2. Sanyal SK, Thapar MK, Ahmed SH, et al. The initial attack of acute rheumatic fever during childhood in north India: a prospective study of the clinical profile. Circulation 1974; 49: 7–12. PMID: 4271711. [DOI] [PubMed] [Google Scholar]
  • 3. Steer AC, Kado J, Jenney AW, et al. Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005–2007. Med J Aust 2009; 190: 133–135. PMID: 19203310. [DOI] [PubMed] [Google Scholar]
  • 4. Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 2011; 3: 67–84. DOI: 10.2147/CLEP.S12977. PMCID: PMC3046187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992; 268: 2069–2073. PMID: 1404745. [PubMed] [Google Scholar]
  • 6. Remenyi B, Carapetis J, Wyber R, et al. ; World Heart Federation. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol 2013; 10(5): 284–292. DOI: 10.1038/nrcardio.2013.34. [DOI] [PubMed] [Google Scholar]
  • 7. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316(8): 421–427. PMID: 3807984. [DOI] [PubMed] [Google Scholar]
  • 8. Manji RA, Witt J, Tappia PS. Cost-effectiveness analysis of rheumatic heart disease prevention strategies. Expert Rev Pharmacoecon Outcomes Res 2013; 13(6): 715–724. DOI: 10.1586/14737167.2013.852470. [DOI] [PubMed] [Google Scholar]
  • 9. Ralph AP, Fittock M, Schultz R, et al. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach. BMC Health Serv Res 2013; 13: 525 DOI: 10.1186/1472-6963-13-525. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from SAGE Open Medical Case Reports are provided here courtesy of SAGE Publications

RESOURCES